To examine the clinical outcomes of long-term infliximab (IFX) treatment in Crohn's disease patients over 15 years.
Retrospective study design
Assessment of clinical remission and treatment adherence
Evaluation of the impact of previous surgeries on treatment outcomes
Early clinical remission was not linked to treatment adherence.
Previous surgery was identified as a potential independent risk factor for treatment failure.
Abstract
Early clinical remission was not associated with the adherence to IFX treatment. Previous surgery may be an independent risk factor for long-term IFX treatment failure.